The uses and differences of R2 and R2* in the determination of iron overload in iron loaded thalassemia patients

Hemoglobin

Volumn 32, Issue 1-2, 2008, Pages 75-83

  Gotsis, Efstathios D ^a  

^a Institute Euromedica Encephalos   (Greece)

Author keywords

Chelation therapy; Deferiprone (L1); Deferoxamine (DFO); Iron overload; Magnetic resonance imaging (MRI); R2; R2*; T 2; T2*; Thalassemia

Indexed keywords

ADOLESCENT; ADULT; BETA THALASSEMIA; BIOPSY; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HUMAN; IRON OVERLOAD; LIVER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAXATION TIME; ARTICLE; BLOOD; CHELATION THERAPY; METABOLISM; METHODOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

FERRITIN; IRON CHELATING AGENT;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHELATION THERAPY; CHILD; FEMALE; FERRITINS; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; SENSITIVITY AND SPECIFICITY;

EID: 39349094697     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260701726293     Document Type: Conference Paper

References (13)

1. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2* magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22(23):2171-2179.
2. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18(1):33-39.
3. Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K, Vasili B, Pennell DJ. Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 2005: 21(5):531-538.
4. Hahn EL. Spin echoes. Phys Rev 1950; 80(4):580-594.
5. Carr HY, Purcell EM. Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 1954; 94(3):630-638.
6. Meiboom S, Gill D. Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instr 1958; 29(8):688-691.
7. Ghurge NR, Coates TD, Nelson MD, Wood JC. Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens. Magn Reson Med 2005; 54(5):1185-1193.
8. Gossuin Y, Roch A, Muller RN, Gillis P. Nuclear magnetic relaxation dispersion of ferritin and ferritin-like particle solutions: a pH effect study. Magn Reson Med 2001; 46(3):476-481.
9. Gossuin Y, Roch A, Lo Bue F, Muller RN, Gillis P. Relaxation induced by ferritin and ferritin-like magnetic particles: te role of proton exchange. Magn Reson Med 2000; 43(2):237-243.
10. Stuhne-Secalec L, Xu SX, Parkes JG, Olivieri NF, Templeton DM. Speciation of tissue and cellular iron with on-line detection by inductively coupled plasma-mass spectrometry. Anal Biochem 1992; 205(2):278-284.
11. St. Pierre TG, Clark PR, Chua-Anuson W, Fleming AJ, Jeffrey GP, Olynk JK, Pootrakul P, Robins E, Lindeman R. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105(2):855-861.
12. Wood JC, Enriquez C, Ghugre N, Tyzka MJ, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106(4):1460-1465.
13. Kontoghiorges GJ, Elacleous E, Economides Ch, Colnagou A. Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations. Curr Med Chem 2005; 12(23):2663-2681.